In October 2001, the National Eye Institute (NEI) one of the Federal Government's National Institutes of Health (NIH) completed a large ten-year study, the Age-Related Eye Disease Study (AREDS). AREDS proved that the formula in Viteyes can slow the progression of Macular Degeneration by 25% in people at risk of developing advanced stages of the disease. Viteyes supplies the AREDS recommended formula in only TWO daily highly soluble, easy-to-swallow capsules.
